(3R,4S,5S,6R)-3-fluoro-6-(hydroxymethyl)tetrahydro-2H-pyran-2,4,5-triol

ID: ALA2068864

PubChem CID: 2737302

Max Phase: Preclinical

Molecular Formula: C6H11FO5

Molecular Weight: 182.15

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Synonyms from Alternative Forms(1): [18F]-Fluorodeoxyglucose

Canonical SMILES:  OC[C@H]1OC(O)[C@H](F)[C@@H](O)[C@@H]1O

Standard InChI:  InChI=1S/C6H11FO5/c7-3-5(10)4(9)2(1-8)12-6(3)11/h2-6,8-11H,1H2/t2-,3-,4-,5-,6?/m1/s1

Standard InChI Key:  ZCXUVYAZINUVJD-IVMDWMLBSA-N

Molfile:  

     RDKit          2D

 12 12  0  0  0  0  0  0  0  0999 V2000
   13.5430  -12.8291    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   13.5430  -14.4791    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   12.1133  -15.3042    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   10.6877  -14.4792    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   12.1132  -12.8291    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   10.0608  -13.3617    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   12.8322  -13.2396    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.8322  -14.0646    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.1132  -14.4792    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.4025  -14.0647    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.4025  -13.2397    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.6877  -12.8292    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  6 12  1  0
 11  5  1  0
  5  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  1
  7  1  1  0
  8  2  1  6
  9  3  1  1
 10  4  1  6
M  END

Alternative Forms

Associated Targets(Human)

PA-1 (704 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: YesOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 182.15Molecular Weight (Monoisotopic): 182.0591AlogP: -2.24#Rotatable Bonds: 1
Polar Surface Area: 90.15Molecular Species: NEUTRALHBA: 5HBD: 4
#RO5 Violations: HBA (Lipinski): 5HBD (Lipinski): 4#RO5 Violations (Lipinski):
CX Acidic pKa: 11.02CX Basic pKa: CX LogP: -2.04CX LogD: -2.04
Aromatic Rings: Heavy Atoms: 12QED Weighted: 0.37Np Likeness Score: 1.83

References

1. El Hilali M, Reux B, Debiton E, Leal F, Galmier MJ, Vivier M, Chezal JM, Miot-Noirault E, Coudert P, Weber V..  (2017)  Linker structure-activity relationships in fluorodeoxyglucose chlorambucil conjugates for tumor-targeted chemotherapy.,  25  (20): [PMID:28927903] [10.1016/j.bmc.2017.08.043]
2. Wijayasinghe YS, Bhansali MP, Borkar MR, Chaturbhuj GU, Muntean BS, Viola RE, Bhansali PR..  (2022)  A Comprehensive Biological and Synthetic Perspective on 2-Deoxy-d-Glucose (2-DG), A Sweet Molecule with Therapeutic and Diagnostic Potentials.,  65  (5.0): [PMID:35192360] [10.1021/acs.jmedchem.1c01737]

Source